Kala Subramanian

2016

In 2016, Kala Subramanian earned a total compensation of $1.7M as Senior Vice President, Strategic Development and Operations at CRISPR Therapeutics AG.

Compensation breakdown

Bonus$150,000
Non-Equity Incentive Plan$67,238
Option Awards$1,271,498
Salary$180,386
Other$2,045
Total$1,671,167

Subramanian received $1.3M in option awards, accounting for 76% of the total pay in 2016.

Subramanian also received $150K in bonus, $67.2K in non-equity incentive plan, $180.4K in salary and $2K in other compensation.

Rankings

In 2016, Kala Subramanian's compensation ranked 5,735th out of 14,075 executives tracked by ExecPay. In other words, Subramanian earned more than 59.3% of executives.

ClassificationRankingPercentile
All
5,735
out of 14,075
59th
Division
Manufacturing
2,080
out of 5,489
62nd
Major group
Chemicals And Allied Products
671
out of 1,895
65th
Industry group
Drugs
502
out of 1,538
67th
Industry
Biological Products, Except Diagnostic Substances
87
out of 279
69th
Source: SEC filing on April 18, 2017.

Subramanian's colleagues

We found three more compensation records of executives who worked with Kala Subramanian at CRISPR Therapeutics AG in 2016.

2016

Rodger Novak

CRISPR Therapeutics AG

Chief Executive Officer

2016

Marc Becker

CRISPR Therapeutics AG

Chief Financial Officer

2016

Samarth Kulkarni

CRISPR Therapeutics AG

Chief Executive Officer

In-depth

You may also like